December 5, 2024 - 21:58

A recent survey indicates that most financial advisors are optimistic about the performance of the S&P 500, forecasting a rise of 10% or more by the end of 2025. The InspereX Pulse 2025 Outlook Survey, which involved 682 advisors from across the United States, revealed that 67% of respondents anticipate a bullish trend for the stock market.
This positive outlook comes amid various economic indicators and market trends that suggest a potential recovery and growth phase. Many advisors are taking into account factors such as consumer spending, corporate earnings, and overall economic resilience when forming their predictions. The sentiment among financial professionals reflects a broader belief in the market's ability to rebound from recent fluctuations.
As investors look toward the future, this forecast may influence investment strategies and decision-making processes. With an expected rise in the S&P 500, financial advisors are encouraging clients to consider long-term investments that could benefit from this anticipated market growth.
May 17, 2026 - 08:31
How Investors Are Reacting To NVE (NVEC) Steady Earnings And Maintained Quarterly DividendNVE Corporation has released its full-year results for the period ending March 31, 2026, posting revenue of US$26.33 million and net income of US$15.2 million. The company also confirmed a...
May 16, 2026 - 22:25
Risky Integration or Rewarding Returns? The Stakes of SoundHound's LivePerson Acquisition.SoundHound AI`s acquisition of LivePerson is drawing mixed reactions from investors, with the immediate fallout hitting the stock price. The deal, which combines SoundHound`s voice AI technology...
May 16, 2026 - 10:38
Bank of Hawaii, Glacier Bancorp, and Wintrust Financial Shares Plummet, What You Need To KnowShares of several regional banks took a sharp hit in afternoon trading Wednesday after the latest inflation report came in hotter than expected. The April Consumer Price Index rose 3.8%, a figure...
May 15, 2026 - 17:39
Plus Therapeutics Shares First Quarter 2026 Financial Results and Updates on REYOBIQ and CNSide ProgressHOUSTON, May 15, 2026 -- Plus Therapeutics, a healthcare company focused on precision diagnostics and radiopharmaceuticals for central nervous system cancers, reported its financial results for the...